- Home
- DOMH vs PYXS Comparison
DOMH vs PYXS Comparison
Compare DOMH & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMH
- PYXS
- Stock Information
- Founded
- DOMH 1967
- PYXS 2018
- Country
- DOMH United States
- PYXS United States
- Employees
- DOMH N/A
- PYXS N/A
- Industry
- DOMH Biotechnology: Pharmaceutical Preparations
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- DOMH Health Care
- PYXS Health Care
- Exchange
- DOMH Nasdaq
- PYXS Nasdaq
- Market Cap
- DOMH 94.0M
- PYXS 79.4M
- IPO Year
- DOMH N/A
- PYXS 2021
- Fundamental
- Price
- DOMH $5.97
- PYXS $2.21
- Analyst Decision
- DOMH
- PYXS Strong Buy
- Analyst Count
- DOMH 0
- PYXS 5
- Target Price
- DOMH N/A
- PYXS $7.75
- AVG Volume (30 Days)
- DOMH 261.5K
- PYXS 900.3K
- Earning Date
- DOMH 11-07-2025
- PYXS 11-11-2025
- Dividend Yield
- DOMH 8.98%
- PYXS N/A
- EPS Growth
- DOMH N/A
- PYXS N/A
- EPS
- DOMH N/A
- PYXS N/A
- Revenue
- DOMH $52,811,000.00
- PYXS $2,820,000.00
- Revenue This Year
- DOMH N/A
- PYXS N/A
- Revenue Next Year
- DOMH N/A
- PYXS N/A
- P/E Ratio
- DOMH N/A
- PYXS N/A
- Revenue Growth
- DOMH 455.38
- PYXS N/A
- 52 Week Low
- DOMH $0.83
- PYXS $0.83
- 52 Week High
- DOMH $13.58
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- DOMH 48.51
- PYXS 79.60
- Support Level
- DOMH $5.90
- PYXS $1.76
- Resistance Level
- DOMH $7.18
- PYXS $2.00
- Average True Range (ATR)
- DOMH 0.45
- PYXS 0.18
- MACD
- DOMH -0.06
- PYXS 0.05
- Stochastic Oscillator
- DOMH 22.93
- PYXS 90.38
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.